EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Smart Macrocycles: Cyclodextrin−Porphyrin Photosensitizers for Photodynamic Therapy in Human Bladder Cancer Cells

Cláudia P S Ribeiro, Rosa Fernandes iD, Leandro M O Lourenço iD

ACS Applied Bio Materials · 03.08.2026 · 9 (15) · 6880-6886

DOI: 10.1021/acsabm.6c00053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 18.03.2026. Verfasst von Cláudia P S Ribeiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro3810-193, Portugal. Hauptthemen laut MEDLINE: Photosensitizing Agents, Porphyrins, Photochemotherapy, Urinary Bladder Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Aveiro, Fundação para a Ciência e a Tecnologia, Ministério da Ciência, Tecnologia e Ensino Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urothelial carcinoma of the bladder is one of the most common malignancies of the urinary tract. It remains a therapeutic challenge due to its high recurrence rate and resistance to conventional treatments. Photodynamic therapy (PDT) is an attractive, minimally invasive alternative that enables spatially controlled tumor ablation by activating photosensitizers (PS) with visible light, generating reactive oxygen species (ROS), mainly singlet oxygen (1O2), and inducing the targeted death of tumor cancer cells. However, due to poor aqueous solubility and aggregation of porphyrin-based PS, their clinical application is often limited. In this study, we report the biological evaluation of three thiopyridinium porphyrin−cyclodextrin conjugates (Por-CD 1a−3a) designed to enhance solubility and cellular delivery while preserving photodynamic activity. In the UM-UC-3 human bladder cancer cell line, we demonstrate that these conjugates exhibit distinct cellular uptake kinetics. PS 1a was rapidly internalized, reaching early saturation within 2 h; PS 2a displayed a gradual and sustained accumulation up to 4 h; and PS 3a demonstrated significant uptake within 30–60 min followed by stabilization. None of the compounds induced significant cytotoxicity in the absence of light at concentrations of 5 or 10 μM, confirming their dark safety profile. After light irradiation, PS 1a−3a produced strong PDT effect, with cytotoxicity profiles directly linked to their absorption properties. PS 1a showed rapid and stable phototoxicity, PS 2a exhibited a slower cytotoxic response, and PS 3a caused intense early phototoxicity even after short incubation periods. These findings indicate that Por-CD conjugates possess favorable cellular internalization and strong PDT efficacy. The three derivatives emerge as promising candidates for optimizing PDT strategies targeting bladder cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPorphyrinsPhotochemotherapyUrinary Bladder NeoplasmsCyclodextrinsAntineoplastic AgentsBiocompatible MaterialsHumansCell Line, TumorMolecular StructureMaterials TestingCell SurvivalDrug Screening Assays, AntitumorDose-Response Relationship, DrugStructure-Activity RelationshipParticle SizeCell Proliferation

Stichwörter der Autor:innen

UM-UC-3 human bladder cancer cellsphotodynamic therapy (PDT)porphyrin−cyclodextrin (Por-CD)reactive oxygen species (ROS)singlet oxygen (1O2)

Substanzen

Photosensitizing AgentsPorphyrinsCyclodextrinsAntineoplastic AgentsBiocompatible Materials

Autor:innen und Institutionen

  • LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro3810-193, Portugal.
  • CQE, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Lisboa1049-001, Portugal.
  • Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra3000-548, Portugal.
  • Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra3000-548, Portugal.
  • Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra3004-504, Portugal.

ORCID-Profile: Rosa Fernandes, Leandro M O Lourenço

Förderung

  • Universidade de Aveiro
  • Fundação para a Ciência e a Tecnologia
  • Ministério da Ciência, Tecnologia e Ensino Superior
  • European Regional Development Fund

Zitieren

APA

Ribeiro, C. P. S., Fernandes, R., & Lourenço, L. M. O. (2026). Smart Macrocycles: Cyclodextrin−Porphyrin Photosensitizers for Photodynamic Therapy in Human Bladder Cancer Cells. ACS Applied Bio Materials, 9(15), 6880-6886. https://doi.org/10.1021/acsabm.6c00053

Vancouver

Ribeiro CPS, Fernandes R, Lourenço LMO. Smart Macrocycles: Cyclodextrin−Porphyrin Photosensitizers for Photodynamic Therapy in Human Bladder Cancer Cells. ACS Applied Bio Materials. 2026;9(15):6880-6886. doi:10.1021/acsabm.6c00053

BibTeX
@article{Ribeiro2026,
  author = {Ribeiro, Cláudia P S and Fernandes, Rosa and Lourenço, Leandro M O},
  title = {Smart Macrocycles: Cyclodextrin−Porphyrin Photosensitizers for Photodynamic Therapy in Human Bladder Cancer Cells},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {15},
  pages = {6880--6886},
  doi = {10.1021/acsabm.6c00053}
}
Kostenlos starten →